Beate Ritz1, Barbara Hoffmann, Annette Peters. 1. University of California, Los Angeles, USA; Institute of Occupational, Social, and Environmental Medicine, University of Düsseldorf; Helmholtz Center Munich and University of Munich.
Abstract
BACKGROUND: Air pollutants, especially fine dust, ozone, and nitrogen dioxide, pose a danger to health worldwide. In 2005, the World Health Organization (WHO), in order to protect public health, issued global recommendations for maximum levels of fine dust (10 μg/m3 for fine dust particles smaller than 2.5 μm [PM2.5]), ozone, and nitrogen dioxide. The recommended levels are regularly exceeded in many places in Germany. METHODS: This review is based on relevant publications retrieved by a selective search in PubMed and, in part, on an expert statement issued in the name of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS). RESULTS: Air pollutants affect the entire body, from the beginning of intrauterine development all the way to the end of life, causing premature death mainly through lung and heart disease. An epidemiological study has shown, for example, that mor- tality rises approximately 7% for every incremental long-term exposure to 5 μg/m3 PM2.5 (95% confidence interval: [2; 13]). Aside from lung and heart disease, the carcinogenic effect of fine dust is now well established. High fine-dust exposure has also been linked to metabolic diseases. For example, in a meta-analysis of cohort studies, the incidence of type 2 diabetes mellitus was found to be associated with elevated fine dust concentrations, with a 25% relative risk increase [10; 43] for every 10 µg/m3 of PM2.5. More recent studies have shown that these substances cause harm even in concentrations that are below the recommended limits. CONCLUSION: It is very important for public health that the current EU standards for rkedly lowered so that health risks can be further reduced, in accordance with the recommendations of the WHO.
BACKGROUND: Air pollutants, especially fine dust, ozone, and nitrogen dioxide, pose a danger to health worldwide. In 2005, the World Health Organization (WHO), in order to protect public health, issued global recommendations for maximum levels of fine dust (10 μg/m3 for fine dust particles smaller than 2.5 μm [PM2.5]), ozone, and nitrogen dioxide. The recommended levels are regularly exceeded in many places in Germany. METHODS: This review is based on relevant publications retrieved by a selective search in PubMed and, in part, on an expert statement issued in the name of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS). RESULTS: Air pollutants affect the entire body, from the beginning of intrauterine development all the way to the end of life, causing premature death mainly through lung and heart disease. An epidemiological study has shown, for example, that mor- tality rises approximately 7% for every incremental long-term exposure to 5 μg/m3 PM2.5 (95% confidence interval: [2; 13]). Aside from lung and heart disease, the carcinogenic effect of fine dust is now well established. High fine-dust exposure has also been linked to metabolic diseases. For example, in a meta-analysis of cohort studies, the incidence of type 2 diabetes mellitus was found to be associated with elevated fine dust concentrations, with a 25% relative risk increase [10; 43] for every 10 µg/m3 of PM2.5. More recent studies have shown that these substances cause harm even in concentrations that are below the recommended limits. CONCLUSION: It is very important for public health that the current EU standards for rkedly lowered so that health risks can be further reduced, in accordance with the recommendations of the WHO.
Authors: Ahmed Karoui; Clément Crochemore; Paul Mulder; David Preterre; Fabrice Cazier; Dorothée Dewaele; Cécile Corbière; Malik Mekki; Cathy Vendeville; Vincent Richard; Jean-Marie Vaugeois; Olivier Fardel; François Sichel; Valérie Lecureur; Christelle Monteil Journal: Environ Pollut Date: 2018-12-17 Impact factor: 8.071
Authors: Michelle C Turner; Michael Jerrett; C Arden Pope; Daniel Krewski; Susan M Gapstur; W Ryan Diver; Bernardo S Beckerman; Julian D Marshall; Jason Su; Daniel L Crouse; Richard T Burnett Journal: Am J Respir Crit Care Med Date: 2016-05-15 Impact factor: 21.405
Authors: Susanne Breitner; Nadine Steckling-Muschack; Iana Markevych; Tianyu Zhao; Hanna Mertes; Dennis Nowak; Joachim Heinrich Journal: Dtsch Arztebl Int Date: 2021-07-26 Impact factor: 5.594